BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-0.01%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.89B
AUM Growth
+$6.89B
(-8.5%)
Cap. Flow
-$366M
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
36.47%
Holding
178
New
7
Increased
49
Reduced
68
Closed
19
Top Buys
| 1 |
Medtronic
MDT
|
$49.2M |
| 2 |
Align Technology
ALGN
|
$30.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$15.6M |
| 4 |
Veeva Systems
VEEV
|
$14.1M |
| 5 |
Legend Biotech
LEGN
|
$7.35M |
Top Sells
| 1 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$159M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$27.3M |
| 3 |
DexCom
DXCM
|
$27.1M |
| 4 |
Cigna
CI
|
$26.9M |
| 5 |
Elevance Health
ELV
|
$26M |
Sector Composition
| 1 | Healthcare | 99.07% |
| 2 | Industrials | 0.84% |
| 3 | Energy | 0.03% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vertex Pharmaceuticals
VRTX
$100B
| $361M | 5.24% | 1,145,695 +49,667 | +5% | +$15.6M |
|
2
Ionis Pharmaceuticals
IONS
$6.79B
| $340M | 4.93% | 9,511,900 -232,000 | -2% | -$8.29M |
|
3
argenx
ARGX
$43.6B
| $330M | 4.8% | 886,928 -24,172 | -3% | -$9.01M |
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $265M | 3.84% | 2,613,300 -159,994 | -6% | -$16.2M |
|
5
Intuitive Surgical
ISRG
$170B
| $247M | 3.59% | 968,786 +11,700 | +1% | +$2.99M |
|
6
Moderna
MRNA
$9.37B
| $238M | 3.46% | 1,551,706 -30,622 | -2% | -$4.7M |
|
7
Incyte
INCY
$16.5B
| $205M | 2.98% | 2,840,500 -116,477 | -4% | -$8.42M |
|
|
ITCI
8
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $177M | 2.57% | 3,268,000 -74,236 | -2% | -$4.02M |
|
9
Alnylam Pharmaceuticals
ALNY
$58.5B
| $177M | 2.57% | 883,250 -37,963 | -4% | -$7.6M |
|
10
Boston Scientific
BSX
$156B
| $172M | 2.5% | 3,439,579 -463,345 | -12% | -$23.2M |
|
11
Abbott
ABT
$231B
| $167M | 2.42% | 1,646,916 -37,563 | -2% | -$3.8M |
|
12
Stryker
SYK
$150B
| $138M | 2.01% | 484,774 -7,460 | -2% | -$2.13M |
|
|
SAGE
13
DELISTED
Sage Therapeutics
SAGE
| $130M | 1.88% | 3,090,000 +120,722 | +4% | +$5.07M |
|
|
AXNX
14
DELISTED
Axonics, Inc. Common Stock
AXNX
| $104M | 1.51% | 1,911,861 +5,400 | +0.3% | +$295K |
|
15
Insulet
PODD
$23.9B
| $103M | 1.5% | 323,594 -22,186 | -6% | -$7.08M |
|
16
Revolution Medicines
RVMD
$7.1B
| $103M | 1.49% | 4,747,900 -107,262 | -2% | -$2.32M |
|
|
17
Medtronic
MDT
$119B
| $99.1M | 1.44% | 1,229,235 +610,815 | +99% | +$49.2M |
|
18
Agios Pharmaceuticals
AGIO
$2.19B
| $92.2M | 1.34% | 4,013,500 -43,292 | -1% | -$994K |
|
19
UnitedHealth
UNH
$281B
| $92.1M | 1.34% | 194,811 -29,483 | -13% | -$13.9M |
|
20
Sarepta Therapeutics
SRPT
$1.78B
| $89.1M | 1.29% | 646,614 -46,595 | -7% | -$6.42M |
|
21
Inspire Medical Systems
INSP
$2.77B
| $88.3M | 1.28% | 377,068 -24,674 | -6% | -$5.78M |
|
|
22
DexCom
DXCM
$29.5B
| $87.7M | 1.27% | 755,079 -233,397 | -24% | -$27.1M |
|
23
Becton Dickinson
BDX
$55.3B
| $86.2M | 1.25% | 348,043 +16,483 | +5% | +$4.08M |
|
24
Edwards Lifesciences
EW
$47.8B
| $86.1M | 1.25% | 1,040,669 -23,462 | -2% | -$1.94M |
|
25
Danaher
DHR
$147B
| $85M | 1.23% | 337,391 -28,959 | -8% | -$7.3M |
|